4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-24-000133
Director sold 6,000 shares at an average $117.00 ($702,029)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FOLETTA MARK G Director | 2024-06-17 | Sale 10b5-1 | −7 | $115.18 | $806 | 62,391 | I |
| FOLETTA MARK G Director | 2024-06-17 | Sale 10b5-1 | −2,212 | $117.16 | $259,159 | 60,179 | I |
| FOLETTA MARK G Director | 2024-06-17 | Sale 10b5-1 | −475 | $117.77 | $55,942 | 59,704 | I |
| FOLETTA MARK G Director | 2024-06-18 | Sale 10b5-1 | −3,007 | $116.75 | $351,065 | 56,697 | I |
| FOLETTA MARK G Director | 2024-06-18 | Sale 10b5-1 | −299 | $117.25 | $35,056 | 56,398 | I |
| Open-market sales · 6,000 sh · avg $117.00 · $702,029 | |||||||
Loading xslF345X05/edgardoc.xml…